Evidence map›Paper›PMID 35987945›Full record

ArticleJournal of molecular modeling2022

Explaining the interaction of mangiferin with MMP-9 and NF-ƙβ: a computational study.

Andy Gálvez-Rodríguez, Anthuan Ferino-Pérez, Zalua Rodríguez-Riera, Idania Rodeiro Guerra, David Řeha, Babak Minofar, Ulises J Jáuregui-Haza

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Andy Gálvez-RodríguezInstituto Superior de Tecnologías Y Ciencias Aplicadas (InSTEC), Universidad de La Habana, La Habana, 10600, Havana, CP, Cuba.
Anthuan Ferino-PérezDepartment of Chemistry, KU Leuven Chem&Tech, Celestijnenlaan 200F, Bus 2404, 3001, Louvain, Belgium.
Zalua Rodríguez-RieraInstituto Superior de Tecnologías Y Ciencias Aplicadas (InSTEC), Universidad de La Habana, La Habana, 10600, Havana, CP, Cuba.
Idania Rodeiro GuerraDepartamento de Farmacología, Instituto de Ciencias del Mar, La Habana, 10600, Havana, CP, Cuba.
David ŘehaLaboratory of Structural Biology and Bioinformatics, Institute of Microbiology of the Czech Academy of Sciences, Zamek 136, 37333, Nove Hrady, Czech Republic.
Babak MinofarLaboratory of Structural Biology and Bioinformatics, Institute of Microbiology of the Czech Academy of Sciences, Zamek 136, 37333, Nove Hrady, Czech Republic.
Ulises J Jáuregui-HazaInstituto Tecnológico de Santo Domingo (INTEC), Avenida de los Próceres #49, Los Jardines del Norte 10602, Santo Domingo, Dominican Republic. Ulises.jauregui@intec.edu.do.
Czech Academy of Sciences · CZHigher Institute of Technologies and Applied Sciences · CUInstituto Tecnológico de Santo Domingo · DOKU Leuven · BE

Funding

Ministerio de Ciencia, Tecnología y Medio Ambiente PN223LH010-029
6 · The paper itself

Abstract

Mangiferin is a glycosylated xanthone widely distributed in nature, which exhibits wide pharmacological activities, highlighting its anti-cancer properties. Mangiferin interferes with inflammation, lipid, and calcium signaling, which selectively inhibits multiple NFkB target genes as interleukin-6, tumor necrosis factor, plasminogen, and matrix metalloproteinase, among others. In this work, the interactions of this polyphenol with MMP-9 and NF-κβ are characterized by using computational chemistry methods. The results show MMP-9 inhibition by mangiferina is characterized for the interact with the catalytic Zn atom through a penta-coordinate structure. It is also demonstrated through a strong charge transfer established between mangiferin and Zn in the QM/MM study. Concerning the mangiferin/NF-κβ system, the 92.3% of interactions between p50 sub-unity and DNA are maintained with a binding energy of - 8.04 kcal/mol. These findings indicate that mangiferin blocks the p50-p65/DNA interaction resulting in the loss of the functions of this hetero-dimeric member and suggesting inhibition of the cancer progression. Experimental results concerning the anti-cancer properties of mangiferin show that this natural compound can inhibit selectively MMP-9 and NF-ƙβ. Although the anti-tumor properties of mangiferin are well defined, its molecular mechanisms of actions are not described. In this work, a computational study is carried out to characterize the interactions of mangiferin with these molecular targets. The results obtained corroborate the anti-proliferative and anti-apoptotic activity of mangiferin and provide a depiction of its mechanisms of action.

Indexed as

Matrix Metalloproteinase 9XanthonesNF-kappa BTumor Necrosis Factor-alphamangiferinMatrix Metalloproteinase 9NF-kappa BTumor Necrosis Factor-alphaXanthonesAnti-cancer activityMangiferinMolecular dockingNatural bond analysisQM/MM

Identifiers

PMID35987945
OpenAlexW4292466999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.